NEURAXIS, INC. Cost of Revenue
NEURAXIS, INC. (NRXS) reported Cost of Revenue of $272.57 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-11
- NEURAXIS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $272.57K, a 85.88% increase year-over-year.
- NEURAXIS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $218.37K, a 56.56% increase year-over-year.
- NEURAXIS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $141.65K, a 34.84% increase year-over-year.
- NEURAXIS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $135.49K, a 39.61% increase year-over-year.
- NEURAXIS, INC. cost of goods and services sold for fiscal 2025 was $562.92K, a 55.50% increase from fiscal 2024.
- NEURAXIS, INC. cost of goods and services sold for fiscal 2024 was $362.00K, a 19.34% increase from fiscal 2023.
- NEURAXIS, INC. cost of goods and services sold for fiscal 2023 was $303.35K, a 2.12% increase from fiscal 2022.
- NEURAXIS, INC. cost of goods and services sold for fiscal 2022 was $297.06K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $272.57K 10-Q · filed 2026-08-11 | $490.94K 10-Q · filed 2026-08-11 | $632.59K derived: sum of 3 quarters · filed 2026-08-11 | $768.08K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $218.37K 10-Q · filed 2026-05-12 | $360.02K derived: sum of 2 quarters · filed 2026-05-12 | $495.50K derived: sum of 3 quarters · filed 2026-05-12 | $642.15K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $141.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $277.14K derived: sum of 2 quarters · filed 2026-03-19 | $423.78K derived: sum of 3 quarters · filed 2026-08-11 | $562.92K 10-K · filed 2026-03-19 |
| 2025-09-30 | $135.49K 10-Q · filed 2025-11-10 | $282.13K derived: sum of 2 quarters · filed 2026-08-11 | $421.26K 10-Q · filed 2025-11-10 | $526.66K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $146.64K 10-Q · filed 2026-08-11 | $286.12K 10-Q · filed 2026-08-11 | $391.17K derived: sum of 3 quarters · filed 2026-08-11 | $488.22K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $139.47K 10-Q · filed 2026-05-12 | $244.53K derived: sum of 2 quarters · filed 2026-05-12 | $341.58K derived: sum of 3 quarters · filed 2026-05-12 | $415.04K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $105.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $202.10K derived: sum of 2 quarters · filed 2026-03-19 | $275.56K derived: sum of 3 quarters · filed 2026-03-19 | $362.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $97.05K 10-Q · filed 2025-11-10 | $170.51K derived: sum of 2 quarters · filed 2025-11-10 | $256.95K 10-Q · filed 2025-11-10 | $317.93K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $73.46K 10-Q · filed 2025-08-12 | $148.54K 10-Q · filed 2025-08-12 | $220.88K derived: sum of 3 quarters · filed 2025-08-12 | $288.17K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $75.08K 10-Q · filed 2025-05-12 | $147.43K derived: sum of 2 quarters · filed 2025-05-12 | $214.71K derived: sum of 3 quarters · filed 2025-05-12 | $282.53K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $72.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $139.63K derived: sum of 2 quarters · filed 2025-03-20 | $207.44K derived: sum of 3 quarters · filed 2025-03-20 | $303.35K 10-K · filed 2025-03-20 |
| 2023-09-30 | $67.29K 10-Q · filed 2024-11-12 | $135.10K derived: sum of 2 quarters · filed 2024-11-12 | $231.00K 10-Q · filed 2024-11-12 | $306.21K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $67.81K 10-Q · filed 2024-08-09 | $163.71K 10-Q · filed 2024-08-09 | $238.93K derived: sum of 3 quarters · filed 2024-08-09 | $306.56K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $95.90K 10-Q · filed 2024-05-20 | $171.11K derived: sum of 2 quarters · filed 2024-05-20 | $238.75K derived: sum of 3 quarters · filed 2024-05-20 | $317.76K derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-12-31 | $75.21K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $142.85K derived: sum of 2 quarters · filed 2024-04-16 | $221.86K derived: sum of 3 quarters · filed 2024-04-16 | $297.06K 10-K · filed 2024-04-16 |
| 2022-09-30 | $67.64K 10-Q · filed 2023-11-20 | $146.65K derived: sum of 2 quarters · filed 2023-11-20 | $221.85K 10-Q · filed 2023-11-20 | |
| 2022-06-30 | $79.01K 10-Q · filed 2023-09-22 | $154.21K 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |